Apyx Medical Corporation Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Outlook

Go back to Apyx Medical Corporation Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Outlook

Apyx Medical Corp. (APYX) Tops Q4 EPS by 5c

March 17, 2022 7:10 AM EDT

Apyx Medical Corp. (NASDAQ: APYX) reported Q4 EPS of ($0.06), $0.05 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $14.63 million.

GUIDANCE:

Apyx Medical Corp. sees FY2022 revenue of $50-63 million, versus the... More